Granulomatous mastitis is a rare, chronic inflammatory condition of the breast that causes painful lumps, abscesses, and sometimes draining wounds that can persist for months or even years. It is not cancer, but it frequently mimics breast cancer on physical exam, imaging, and even initial biopsies, which makes getting the right diagnosis frustratingly slow for many people. The condition overwhelmingly affects women of childbearing age, and despite decades of research, there is no single agreed-upon cause or cure. Treatment typically involves some combination of steroids, other immune-suppressing medications, antibiotics, or surgery, but recurrence is common and the path to remission is rarely straightforward.
What It Looks Like and Why It Gets Mistaken for Cancer
The most common first sign is a firm, tender lump in one breast, often accompanied by redness, swelling, and skin thickening. Over time, that lump may progress to an abscess that can drain through the skin, forming sinus tracts. The presentation is alarming partly because it looks so much like inflammatory breast cancer or other malignancies on clinical exam. Mammograms may show a suspicious mass or asymmetry, and ultrasound often reveals an irregular, dark lesion with angular borders.1PubMed Central. Idiopathic granulomatous mastitis: imaging update and review MRI, when used, tends to show strong enhancement that can further raise cancer suspicion.2PubMed. Idiopathic Granulomatous Mastitis: Manifestations at Multimodality Imaging and Pitfalls
This mimicry is not a rare footnote. Reports document granulomatous mastitis simulating breast cancer across all parts of standard diagnostic workup, including physical exam, radiology, and cell sampling. It has even been described in a male patient.3PubMed. Granulomatous mastitis can mimic breast cancer on clinical, radiological or cytological examination: a cautionary tale The practical consequence is that many people go through the anxiety of a possible cancer diagnosis before a tissue biopsy finally reveals the actual problem. Misdiagnosis can also lead to repeated core biopsies, which themselves may cause fistulae and sinus tracts, making the disease harder to manage down the road.4PubMed. You’ll see it when you know it: granulomatous mastitis
How the Diagnosis Is Made
There is no blood test or imaging finding that definitively confirms granulomatous mastitis. The diagnosis depends on histopathology, meaning a tissue sample examined under a microscope. The hallmark is clusters of inflammatory cells arranged in granulomas that sit within the breast’s milk-producing lobules, without the dead-tissue center (caseation) you would see in tuberculosis.5PubMed Central. Granulomatous lobular mastitis The typical microscopic picture includes collections of immune cells called epithelioid histiocytes, sometimes with multinucleated giant cells, along with clusters of neutrophils.6Archives of Breast Cancer. Idiopathic Granulomatous Mastitis: Diagnosis and Histopathologic Features, A Review
Before settling on the “idiopathic” label (meaning no known cause), doctors need to rule out other things that cause granulomas in the breast. Tuberculosis of the breast is probably the most important condition to exclude, especially in regions where TB is common. One study found that TB patients tended to be older (average age 40 vs. 33 for idiopathic cases), were more likely to have enlarged armpit lymph nodes, and half had TB elsewhere in the body.7PubMed Central. Differential diagnosis in idiopathic granulomatous mastitis and tuberculous mastitis Other conditions on the list include sarcoidosis, fungal infections, and reactions to foreign materials. Special stains and cultures on the biopsy tissue help sort through these possibilities.
Who Gets It
Granulomatous mastitis predominantly affects women in their 20s through 40s, typically within a few years of pregnancy or breastfeeding. It is rare overall, but it is not equally distributed across populations. In the United States, Hispanic and Latina women have roughly a six-fold higher likelihood of developing the condition compared to non-Hispanic, non-Latina counterparts.8PubMed. Clinical Trends in Granulomatous Mastitis Incidence, Prevalence, and Treatment: A Retrospective Study Highlighting Ethnic Differences in Care A case-control study reinforced this pattern, finding that patients who preferred Spanish as their primary language had about four times the odds of having the condition, and that being born in Mexico was independently associated with higher risk.9Journal of Breast Imaging. Demographic and Socioeconomic Risk Factors for Granulomatous Mastitis in the United States: A Case-Control Study
The same study found socioeconomic factors tangled into the picture: patients with granulomatous mastitis were more likely to lack a primary care provider and to be on safety-net insurance programs.10Journal of Breast Imaging. Demographic and Socioeconomic Risk Factors for Granulomatous Mastitis in the United States: A Case-Control Study Whether the ethnic disparity reflects genetic susceptibility, environmental factors, differences in healthcare access leading to delayed diagnosis, or some combination remains unclear. High rates have also been reported in Middle Eastern and South Asian populations outside the U.S., suggesting that the association is not unique to one country’s healthcare system.
What Causes It
The honest answer is that nobody is certain. The condition is labeled “idiopathic” precisely because no single cause has been proven, but several converging lines of evidence point toward an autoimmune process modulated by hormonal and possibly microbial factors.
The strongest argument for autoimmunity is that many patients respond to steroids and other immune-suppressing drugs, and some develop concurrent autoimmune conditions like erythema nodosum (painful red nodules on the shins), arthritis, or autoimmune thyroid disease.11PubMed. Idiopathic granulomatous mastitis as an autoimmune disease: A review of immunopathogenesis and therapeutic response Molecular studies have found elevated inflammatory signaling, impaired regulatory immune cell function, and genetic associations with specific immune-system genes.12PubMed Central. Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches
The Prolactin Connection
Prolactin, the hormone responsible for milk production, appears to play a role. The disease is strongly linked to recent pregnancy and breastfeeding, and the prevailing theory is that milk stasis (retained milk in the ducts) triggers an inflammatory reaction.13PubMed Central. Drug-Induced Hyperprolactinemia and Granulomatous Mastitis: A Case Report and Literature Review More strikingly, some cases have been linked to elevated prolactin from other causes, including medications that raise prolactin levels and even pituitary tumors. In at least one documented case, removing a brain tumor that was driving high prolactin led to complete resolution of the breast inflammation, suggesting a direct hormonal trigger.14PubMed. Association between Hyperprolactinemia and Granulomatous Mastitis Some researchers now recommend checking prolactin levels in patients who have no recent history of pregnancy or breastfeeding and no other obvious cause.15PubMed. Association between Hyperprolactinemia and Granulomatous Mastitis
The Bacterial Question
A bacterium called Corynebacterium kroppenstedtii has gained attention over the past two decades as a possible contributor. This organism is lipophilic (fat-loving), which may explain why it thrives in breast tissue. One retrospective study found C. kroppenstedtii in about 8% of all breast abscess patients but in roughly a third of those with chronic abscesses.16PubMed. Corynebacterium kroppenstedtii breast abscesses in context, a retrospective cohort study When the bacterium is present, patients appear more likely to develop sinus tracts and to experience recurrence.17PubMed Central. Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
Whether the bacterium is a cause of the inflammation or an opportunistic bystander that colonizes already-damaged tissue remains debated. The practical implication, regardless, is that culture results can guide treatment: when Corynebacterium is found, targeted antibiotics may improve outcomes.
Treatment with Corticosteroids
Oral steroids are the most widely used first-line medical therapy. In a prospective study of 88 patients treated with methylprednisolone starting at 20 mg per day, about 81% responded well. The dose was gradually tapered over months, and the median total treatment duration for those who completed the course was nearly four months.18PubMed Central. Methylprednisolone for idiopathic granulomatous mastitis: a prospective observational cohort study Relapse during tapering is a real concern: about 10% of responders in that study flared during steroid withdrawal, and among those who completed the full course, roughly a third relapsed within a follow-up period averaging about nine months.19PubMed Central. Methylprednisolone for idiopathic granulomatous mastitis: a prospective observational cohort study
Timing matters. A retrospective analysis found that response rates were highest when steroids were started during the lump stage (about 78%) and lower once an abscess or sinus tract had formed. The same study found that maintaining a low dose for three months after the inflammation appeared controlled helped reduce both recurrence rates and side effects. Weight gain was the most common side effect, affecting about 39% of patients.20Journal of Inflammation Research. Optimal Timing for Corticosteroid Therapy in Idiopathic Granulomatous Mastitis: A Retrospective Analysis Highlighting Early Intervention Efficacy
When Steroids Are Not Enough
For patients who do not respond to steroids alone or who relapse repeatedly, the next step is usually adding methotrexate, a drug more commonly associated with rheumatoid arthritis treatment. A study comparing high-dose steroids alone against low-dose steroids plus methotrexate found the combination group had a shorter overall treatment duration (about 11.5 vs. nearly 15 months) and a lower recurrence rate (roughly 5% vs. 23%). When relapses did occur, they happened much later in the combination group.21PubMed Central. Methotrexate plus low-dose prednisolone compared with high-dose corticosteroid therapy in the management of idiopathic granulomatous mastitis A randomized clinical trial of patients with refractory or recurrent disease found that steroids combined with disease-modifying drugs like methotrexate achieved complete response in over 94% of cases.22PubMed. Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial
Methotrexate with low-dose steroids is increasingly seen as preferable to high-dose steroids alone, particularly for patients who cannot tolerate the side effects of prolonged steroid use or whose disease keeps bouncing back.23PubMed Central. Low-Dose Methotrexate Use in Idiopathic Granulomatous Mastitis: An Alternative Treatment Method Newer molecular work identifying specific inflammatory pathways has also raised interest in biologic agents like anti-TNF drugs and JAK inhibitors, though these remain less studied in this context.24PubMed. Idiopathic granulomatous mastitis as an autoimmune disease: A review of immunopathogenesis and therapeutic response
The Role of Antibiotics
Antibiotics occupy an interesting and somewhat controversial place in granulomatous mastitis treatment. Because about half of patients in some series have bacteria identified in their tissue cultures, and because some of those bacteria are plausible contributors to the inflammation, antibiotics are not just incidental. One group that used lipophilic antibiotics (drugs that penetrate fatty tissue well) as their preferred first-line therapy reported treating over 90% of their patients with antibiotics, most commonly clarithromycin. The average treatment duration was about seven months.25PubMed Central. Treatment of Granulomatous Mastitis: Is There a Role for Antibiotics?
When Corynebacterium species are confirmed on culture, specific antibiotic choices make a notable difference. In one study, patients treated with tetracycline-class drugs had an 87.5% response rate, those on rifampin had 100%, while those given cephalosporins responded only about 11% of the time.26Infect Dis Clin Microbiol. Corynebacterium in Granulomatous Mastitis: Clinical Features and Treatment Outcomes The poor response to cephalosporins is worth knowing because those are among the most commonly prescribed antibiotics for breast infections in general, meaning a patient whose cultures are not checked may get the wrong drug.
Surgery and the Case Against Operating Too Early
Surgery was once the default approach, but the evidence has shifted. A meta-analysis comparing surgical and nonsurgical treatment found no significant difference in recurrence rates.27PubMed Central. Comparison of Conservative versus Surgical Treatment Protocols in Treating Idiopathic Granulomatous Mastitis: A Meta-Analysis More striking, a ten-year single-center study found that patients who had surgery combined with medical treatment actually recurred at more than double the rate of those who received medical treatment alone (about 54% vs. 25%).28Asian Journal of Surgery. The recurrence outcome with respect to treatment choices in idiopathic granulomatous mastitis: A retrospective cohort study with 10-year single-center experience That does not necessarily mean surgery caused the recurrence; it may reflect that patients who end up on the operating table had more severe disease to begin with. Still, the pattern has made most specialists cautious about recommending surgery upfront. Surgical excision now tends to be reserved for cases that have truly failed medical management or for very localized disease where a clean excision can be performed without significant cosmetic impact.
A systematic review pooling data from over 4,000 patients calculated an overall recurrence rate of about 17%. Broken down by treatment type, surgery alone had a recurrence rate of about 22.5%, immunosuppressive therapy about 14.7%, and antibiotic-only treatment had the lowest rate at roughly 6.7%.29PubMed Central. Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review Observation alone (watchful waiting) had a recurrence rate of about 9.4%, which raises the provocative question of whether some patients would do just as well without aggressive treatment.30PubMed Central. Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review
Intralesional Steroid Injections
One of the more promising developments in treatment is the use of steroid injections directly into the affected breast tissue rather than relying entirely on oral steroids. The appeal is straightforward: delivering the drug straight to the site of inflammation means you can use higher local concentrations while avoiding much of the systemic fallout. A systematic review found that the overall complication rate with intralesional injections was about 3.8%, compared to roughly 10% for oral steroids and 8.3% for surgery. The complications that did occur were minor: bruising, mild skin thinning, and redness at the injection site. The approach avoids the weight gain, blood-sugar spikes, and bone-thinning that come with months of oral steroids.31PubMed Central. The Use of Intralesional Corticosteroids in Idiopathic Granulomatous Mastitis: A Systematic Review
Some clinicians now use intralesional injections as a first-line approach for severe disease, either alone or combined with a short course of oral steroids.32PubMed Central. Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy This approach is also especially relevant for patients who are breastfeeding, since the systemic exposure is lower.
Recurrence and What Drives It
If there is one thing that defines the patient experience of granulomatous mastitis, it is the cycle of flare and remission. A multicentre study found that history of pregnancy, breastfeeding, prior breast infection, and smoking were all significantly associated with recurrence.33PubMed. Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study? Separate research found that oral contraceptive use was significantly higher among patients who relapsed compared to those who stayed in remission.34PubMed Central. Clinical, histological features, and predictors of relapse in patients with idiopathic granulomatous mastitis The hormonal thread running through all of these risk factors is hard to miss: pregnancy, breastfeeding, and oral contraceptives all influence prolactin and estrogen levels, reinforcing the idea that hormonal fluctuation is part of the disease’s engine.
The good news is that the condition does eventually burn itself out for most people. It is not progressive in the way that an uncontrolled autoimmune disease can be. But “eventually” can mean years of intermittent pain, drainage, and repeated courses of medication, which takes a real toll.
The Emotional and Physical Toll
Research into quality of life paints a difficult picture. The cycle of recurring pus, open wounds, and breast pain causes major changes in emotional and physical wellbeing. Qualitative interviews with women living with the condition found that negative emotions, reduced self-confidence, lower sleep quality, and withdrawal from social activities were common. Economic pressure and reduced parent-child communication added to the burden.35PubMed Central. The Disease Experience of Women with Granulomatous Lobular Mastitis. A Qualitative Interview Study A separate survey-based study found significant levels of depression and anxiety among patients and concluded that they need more help managing not just pain and fatigue but also psychological distress. The authors argued that characterizing the disease as “benign” underestimates its real impact on the people living with it.36Breast Care. Granulomatous Mastitis Is Not as Benign as You Might Think: What Doctors Need to Know about the Lived Experience of People with This Rare Disease
The label “benign” is technically correct in that granulomatous mastitis is not malignant and does not spread like cancer. But for someone dealing with months of an open wound on their breast, multiple specialist visits, repeated medication changes, and the cosmetic damage that can result from abscesses and sinus tracts, the word “benign” can feel like a dismissal. Advocacy from both patients and researchers has pushed for better recognition that chronic breast conditions deserve coordinated care that includes psychological support.
Managing the Condition During Pregnancy and Breastfeeding
Because granulomatous mastitis overwhelmingly affects women in their reproductive years, it sometimes arises during pregnancy or while breastfeeding, creating a clinical dilemma. Systemic steroids during early pregnancy carry risks including cleft lip and palate, preterm delivery, and low birth weight. During lactation, oral steroids can reduce milk production.37PubMed Central. Granulomatous Mastitis Occurring during Pregnancy: A Case Report
A diagnosis does not mean you have to stop breastfeeding. Patients may face difficulties with milk production and latch on the affected side, but breastfeeding from the unaffected breast can continue. Intralesional steroid injections offer a middle ground, providing relief while limiting systemic drug exposure. When the affected breast is being treated with local injections, clinicians generally advise weaning on that side while supporting milk production on the other.38PubMed Central. Management of idiopathic granulomatous mastitis in lactation: case report and review of the literature The overall approach needs to be individualized, balancing the severity of the disease against the patient’s goals for breastfeeding and the safety profiles of available treatments.